T1	Participants 39 83	patients with resected renal cell carcinoma:
T2	Participants 390 473	Patients with surgically resected locally advanced (T3-4 or N1-2) or metastatic RCC
T3	Participants 231 367	patients with resected renal cell carcinoma (RCC) at high risk for recurrent disease (TNM stages III and IV resected distant metastases)
